Trevi Therapeutics, Inc. - stock earnings
TRVI Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -7.8 million USD | ? USD |
| 2023Q3 | -7.7 million USD | ? USD |
| 2023Q2 | -7.1 million USD | ? USD |
| 2023Q1 | -6.4 million USD | ? USD |
| 2022Q4 | -5.5 million USD | ? USD |
| 2022Q3 | -8.3 million USD | ? USD |
| 2022Q2 | -8.1 million USD | ? USD |
| 2022Q1 | -7.3 million USD | ? USD |
| 2021Q4 | -8.5 million USD | ? USD |
| 2021Q3 | -7.3 million USD | ? USD |
| 2021Q2 | -9.8 million USD | ? USD |
| 2021Q1 | -8.4 million USD | ? USD |
| 2020Q4 | -9.5 million USD | ? USD |
| 2020Q3 | -7.4 million USD | ? USD |
| 2020Q2 | -7.4 million USD | ? USD |
| 2020Q1 | -8.5 million USD | ? USD |
| 2019Q4 | -6.5 million USD | ? USD |
| 2019Q3 | -7.4 million USD | ? USD |
| 2019Q2 | -7.3 million USD | ? USD |
| 2019Q1 | -4.8 million USD | ? USD |
| 2018Q4 | -6.0 million USD | ? USD |
| 2018Q3 | -5.7 million USD | ? USD |
| 2018Q2 | -4.9 million USD | ? USD |
| 2018Q1 | -4.1 million USD | ? USD |
| 2017Q4 | -2.4 million USD | ? USD |
TRVI Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -29.1 million USD | ? USD |
| 2022 | -29.2 million USD | ? USD |
| 2021 | -33.9 million USD | ? USD |
| 2020 | -32.8 million USD | ? USD |
| 2019 | -26.1 million USD | ? USD |
| 2018 | -20.5 million USD | ? USD |
| 2017 | -12.9 million USD | ? USD |
| 2016 | -11.1 million USD | ? USD |
TRVI
Price: $3.02
52 week price:
Earnings Per Share: -0.29 USD
P/E Ratio: -7.45
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 28000
Market Capitalization: 201.4 million